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Nitric Oxide Synthase Is Not a Constituent of the Antimicrobial Armature of
Human Mononuclear Phagocytes
Markus Schneemann, Gabriele Schoedon, Simone Hofer,
Nenad Blau, Lourdes Guerrero, and Andreas Schaffner
Clinical Mycology Laboratory, Division oj Infectious Diseases.
Department ofMedicine. University oJZurich Medical School. Switzerland
Nitric oxide synthase (NOS) has received immense interest as an antimicrobial and antitu-
moral effector system of mononuclear phagocytes from rodents. Because there is increasing
doubt that an analogous system exists in human macrophages, NOS was reexamined in these
cells. Under tightly controlled conditions, with murine macrophages as positive controls, human
macrophages failed to secrete nitric oxide «0.1 #Lmol/106 cells/24 h), even after activation with
endotoxin, intcrferon-v, granulocyte-macrophage colony-stimulating factor, tumor necrosis fac-
tor-a, bacteria, or proliferating lymphocytes. The discrepancy between murine and human macro-
phages depended on neither the anatomic source (blood, peritoneum), the agent used for activa-
tion, nor the duration of activation. NOS activity was paralleled by metabolization of L-arginine
to L-citrulline. Exogenous tetrahydrobiopterin, an essential cofactor of NOS not synthesized by
human macrophages, did not support NOS activity in human macrophages. Also, no NOS
activity was found in cellular subfractions of human macrophages. It appears that in humans, the
inducible high-output NOS is not conserved as an antimicrobial system of macrophages.
Nitric oxide (NO) has recently been brought into focus as
an antimicrobial and antitumoral effector system ofmononu-
clear phagocytes with activity against fungi [1,2], bacteria [3,
4], parasites [5-8], and tumor cells [9-15]. While there is
general agreement that phagocytes from mice and rats synthe-
size abundant NO from L-arginine [I, 7, 16-19], demonstra-
tion of high-output NO synthase (NOS) activity in human
mononuclear phagocytes remains controversial. On one
hand, it has been proposed that the antimicrobial activity of
human blood-derived macrophages, seen after prolonged
activation against Mycobacterium aviuni-Mycobacteriurn in-
tracellulare [3] or Trypanosoma cruzii [20], depends on NO.
On the other hand, human peritoneal, alveolar, and blood-
derived macrophages have not been found to secrete sub-
stantial amounts of NO [21-24], even after treatment with
endotoxin (lipopolysaccharide, LPS) and interferon-v (IFN-
'Y). Also nitrite, a descendant of NO that is unstable under
physiologic conditions, was not detectable in supernatants
from human macrophages stimulated with LPS and IFN-')"
[23-25]. Furthermore, alveolar and peritoneal macrophages
have not been found to metabolize appreciable amounts of
L-arginine, the substrate of NOS [21].
Because of the significance attributed to the effector func-
tion ofNO produced by mouse and rat macrophages [26-28]
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and the continuous efforts put into studies of NOS in mono-
nuclear phagocytes [8,20, 29-32], we decided to reexamine
NOS activity in human macrophages.
Materials and Methods
Phagocytes. Human mononuclear cells were isolated from
heparinized blood of normal volunteers by a Ficoll gradient
(Pharrnacia, Uppsala, Sweden), and lymphocytes were washed
away after adhesion of the mononuclear phagocytes to the bot-
toms of culture wells, giving a monocyte preparation of >95%
purity as determined by Giemsa stain [33]. Human peritoneal
macrophages were obtained by centrifugation, washing, and ad-
hesion purification of dialysate from patients undergoing
chronic peritoneal dialysis or with malignant ascites. Mouse peri-
toneal macrophages were obtained from female 8- to 10-week-
old ICR, BALB/c (Institut fiir Tierzucht, University ofZurich),
or C3H/HeN mice (WIGA, Sulzfeld. Germany) as resident cells
or collected 5-6 days after stimulation with 2 mL of 10% thio-
glycolate broth (Difco, Detroit) or 2% starch (Merck, Zurich) by
lavage with 10 mL ofcold Gey's balanced salt solution (GIBCO
Europe, Basel, Switzerland) supplemented with 10 units/rnl.
heparin (Hoffmann La Roche, Basel). Blood-derived (heparin-
ized blood, Ficoll) and thioglycolate-induced (20 mL/rabbit)
peritoneal macrophages were obtained from 2-kg New Zealand
White rabbits (Madoring, Fullinsdorf, Switzerland), and mono-
nuclear phagocytes were prepared as described above.
Cell cultures. Mononuclear phagocytes were cultured in 24-
or 6-well cluster plates (Falcon Plastics, Oxnard, CA) for mea-
surement of NO secretion, NOS, amino acid metabolism, or
biopterin synthesis. Phagocytes were seeded at a density ofO.4-
0.5 X 105 mononuclear phagocytes/cm? of culture surface and
cultured with 1 mL of mcdium/ l O"cells. Medium 199 (GIBCO)
was supplemented with 15% fetal calf serum (GIBCO) for mice
and 20% human or 20% rabbit serum for human or rabbit phago-
cytes, respectively, in addition to 500 #Lmol L-arginine (Fluka,
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Results
Table 1. Comparison of nitrite (NOi) secretion by macrophages
from different species and anatomic sources.
were deproteinated by centrifugation through Ultrafree-MC
NMWL filter units with a cutoff of 10,000 Da (Millipore, Bed-
ford, MA). Analysis was developed by a stepwise gradient of
lithium citrate ranging from O.IS to 1.4 N Li. Amino acids were
quantitated by the ninhydrin reaction at 570 and 440 nm.
NOTE. Human peritoneal macrophages were from peritoneal dialysate
fluid (I experiment) or from inflammatory ascites (2 experiments). Perito-
neal macrophages from rodents were either resident or obtained after intra-
peritoneal stimulation with 10%thioglycolate or 2%starch. Data are mean ±
SE from triplicate experiments. LPS. Escherichia coli endotoxin (lipopolysac-
charide). 200 ng/ml.; IFN--y. recombinant interferon-v from corresponding
species. 100 units/rnl.: BH4 • tetrahydrobiopterin, 0.5 mmol.
<0.1
<0.1
<0.1
<0.1
<0.1
<0.1
<0.1
<0.1
<0.1
1.9 ± 0.4
5.5 ± 0.1
59.9 ± 5.0
1.8 ± 0.4
10.5 ± 1.3
44.3 ± 4.4
51.3 ± 4.4
54.7 ± 1.5
6.64 ± 1.4
15.6 ± 2.2
25.5 ± 2.2
38.3 ± 2.9
<0.1
<0.1
<0.1
<0.1
N02 (umol/ I 06
cells/day)
Pretreatment
for 48 h
None
LPS
IFN--y
IFN--y + LPS
IFN--y + LPS + BH4
None
LPS
IFN--y + LPS
IFN--y + LPS + BH4
None
LPS
IFN--y
None
LPS
IFN--y
IFN--y + LPS
IFN--y + LPS + BH4
None
LPS
IFN--y
IFN--y + LPS
None
LPS
None
LPS
Mouse starch
Mouse resident
Rabbit thioglycolate
Rabbit blood
When we compared the amount of NO secreted by hu-
man, murine, or lapine mononuclear phagocytes, we found
in five independent experiments that macrophages from
mice but not from humans or rabbits secreted NO in
amounts detectable by quantification of nitrite in culture su-
pernatants (table I). Human and lapine mononuclear phago-
cytes consistently failed to build up detectable nitrite con-
centrations in culture supernatants, even after stimulation
with LPS or IFN-'Y, while the same stimuli resulted in a 2.5-
to 30-fold increase of nitrite concentrations in supernatants
from murine peritoneal macrophages. To control for activa-
tion of human macrophages, listericidal and H 20 2 activity
Human peritoneal
Mouse thioglycolate
Human blood
Cell source
Buchs, Switzerland) and 50 ILg/mL gentamycin (Schering, Ken-
ilworth, NJ). Medium was changed every 48 h.
Cvtokines, hormones. and stimulants. Human recombinant
IFN-'Y was from Biogen (Geneva), recombinant granulocyte-
macrophage colony-stimulating factor (GM-CSF) from Scher-
ing, recombinant tumor necrosis factor-a (rTNFa) from Knoll
(Ludwigshaven, Germany), and recombinant human interleu-
kin-2 (rlL-2) from Hoffmann La Roche. Mouse recombinant
IFN-'Y was a gift of K. Frei (Institute for Clinical Immunology.
University of Zurich). LPS (Escherichia coli 026:B6, Boivin ex-
traction) was from Difco: purified protein derivative (PPD) for
in vitro use was from the Statens Serumsinstitut (Copenhagen).
All supplements were directly dissolved and diluted in medium
199 with the exception oftetrahydrobiopterin (BH 4 ; B. Schircks
Laboratories, Jona, Switzerland). which was dissolved in 0.05 M
HCI as a 100 mM stock solution. In some experiments, heat-
killed bacteria (l08/mL) of Listeria monocytogenes(strain EGD)
or Moraxella catarrhalis (gift of R. Keller, Arbeitsgruppe fllr
Immunbiologie, University of Zurich Medical School) were
used to induce NOS [34].
Quantitation ofnitrite. To ISO ILL of Griess reagent (0.05%
N-I-naphthylethylenediamine dihydrochloride, 0.5% sulfanila-
mide 2.5% phosphoric acid), 50 ILL of supernatant from macro-
phage cultures was added and incubated at room temperature
for 10 min in a 96-well microplate (Dynatech, Kloten Switzer-
land). Absorbance was read at 570/630 nm in a MicroELISA
Autoreader MR 580 (Dynatech). Sodium nitrite was used as
NOi standard diluted in complete medium, and the measured
amount ofNOi was related to the number of cells in the corre-
sponding well. Cell counts were obtained electronically by a
counter (Coulter. Hialeah, FL) as described [33, 35]. Under
these conditions, the detection limit was 0.1 ILM nitrite/ I06 cells
or 10 pmoljmicrowell. Activation of human macrophages by
cytokines was assessed by monitoring antilisterial activity and
H202 secretion by methods described previously [35].
Assayfor NOS. Macrophage monolayers from 6-well cluster
plates (35 mm) were washed twice with IS mM HEPES, pH 7.5,
and were harvested by scraping in 500 ILL of the same buffer
containing I mg/mL 2-macroglobulin. Then 50 mL of this sus-
pension was collected for determination of cell numbers (see
above). Cells were disrupted by sonication and centrifuged for
30 min at 50,000 gat 4°C. NOS activity in the supernatants was
measured as described [34] with the following modifications:
The reaction mixture contained IS mM HEPES, pH 7.5, I mM
MgCI2 , I mM dithioerythritol (DTE), 60 ILM BH4 , 0.1 mM
NADPH, I mM t-arginine, and macrophage lysate in a total
volume of 300 ILL. The mixture was incubated in the dark at
37°C for 6 h. The reaction was stopped by freezing at -70°C.
Samples were assayed for nitrite formation using the Griess reac-
tion as described above. Then 100 ILL of the assay mixture was
incubated with 100 ILL of Griess reagent and read against a so-
dium nitrite standard dissolved in IS mM HEPES, pH 7.5, con-
taining MgCI 2 , DTE, NADPH, and L-arginine at concentrations
used in the assay mixture.
Amino acid analysis. Amino acid contents in macrophage
culture supernatants were quantitated by a routine procedure
using an LC 500 I Autoanalyzer equipped with BTC 2710 cat-
ion exchange resin (Biotronik, Maintal, Germany). Samples
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Figure 2. Comparison ofL-arginine consumption, ornithine, cit-
rulline, and nitrite secretion by human and murine peritoneal mac-
rophages stimulated by combination of 200 ng/mL endotoxin and
100 units/nil, interferon-v for 48 h. Concentrations measured in
48-h culture supernatants (mean from duplicate wells).
stimuli of high-output NOS in murine macrophages [34,36],
or a complete effector system of cell-mediated immunity
consisting of autologous sensitized lymphocytes, PPD, and
11-2 [33] completely failed to induce NOS activity. In con-
trast, the same stimuli studied in parallel provoked nitrite
production of 16-54 1Lmolj I06 cells/24 h in thioglycolate-
elicited murine macrophages.
It has been speculated that the failure to demonstrate NO
production by human mononuclear phagocytes in vitro
might represent an in vitro artifact because cytokines were
found to augment urinary nitrate output in humans [22]. On
the basis of such speculations, one could consider the possi-
bility that nitrite measurement in culture supernatants would
not be appropriate to detect NO production by human macro-
phages, for example because NO would be quenched and
would not transform to nitrite. To exclude this possibility,
we followed the fate of L-arginine, the substrate of NOS, in
human and murine macrophages. Neither blood-derived nor
peritoneal human macrophages consumed substantial
amounts of t-arginine compared with murine macrophages,
even after full stimulation with LPS, IFN-')' , GM-CSF, or
TNFa, and accordingly produced neither NO nor citrulline,
the deamination product ofNOS (figures 1,2). Furthermore,
human mononuclear phagocytes, as distinct from murine
macrophages, also did not metabolize detectable amounts of
L-arginine in the urea cycle to ornithine and urea (figures I,
2). When we compared quantitatively the consumption of
L-arginine by human macrophages to that of 18 other amino
acids, we found that L-arginine (which was purposely
enriched in culture medium) was not consumed by human
macrophages in excess of other amino acids. This indicates
that L-arginine was principally used by human phagocytes
for protein synthesis. Also in this respect, human cells con-
trasted with murine macrophages, which consumed 50-80
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were monitored after treatment with IFN-')' and LPS. Acti-
vated cells showed an increase of HzOz secretion by a factor
of 4-9 and of listericidal activity by a factor of 2-5 (not
shown).
The difference between the NOS activity of human, lap-
ine, and murine macrophages did not appear to depend on
the anatomic source of the phagocytes, because not only
blood-derived but also peritoneal macrophages from humans
and rabbits gave equivalent results (table I). Also, when peri-
toneal cells were tested, there was no interspecies difference
in whether mouse or rabbit macrophages were elicited or
resident or in human cells whether macrophages were ob-
tained from peritoneal dialysate fluid or from inflammatory
ascitic effusions (table I).
Because human mononuclear phagocytes did not synthe-
size tetrahydrobiopterin (BH 4) , an essential cofactor ofNOS,
we investigated also whether supplementation of exogenous
BH4 would give rise to the secretion ofNO by human macro-
phages. Even under these conditions, no NO was produced
by human cells (table I).
Next we studied whether stimuli other than LPS or IFN-')',
known to activate macrophages, would induce NOS activity
in human mononuclear phagocytes or whether a prolonged
stimulation for up to 12 days would be effective. Stimulation
with IFN-')' (at 100 units/rnl), IFN-')' plus LPS (200 ng/rnl.),
IFN-')' plus LPS plus BH4 (0.5 mrnol), GM-CSF (100 ng/
rn l.), GM-CSF plus TNFa (l00 units/rnl.), GM-CSF plus
IFN-')', or GM-CSF plus TNFa plus IFN-')' for up to 12 days
did not induce any detectable nitrite secretion «0.1 1Lmol/
106 cell/day). Similarly stimulation with 108 heat-killed Lis-
feria monocytogenes or Moraxella catarrhalis, both potent
Figure 1. Comparison of consumption of L-arginine and release
of ornithine and citrulline into culture medium by mouse perito-
neal and human blood-derived macrophages. Endotoxin (lipopoly-
saccharide, LPS), 200 ng/mL; interferon-v (IFN-'Y), 100 units/ml.:
granulocyte-macrophage colony-stimulating factor (GM-CSF),
100 ng/rnl.; tumor necrosis factor-a (TNFa), 100 units/rnl., Con-
centrations measured in 48-h culture supernatants (mean ± SO
from triplicate wells).
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Discussion
Table 2. Summary of differences between NOS activity, tetrahy-
drobiopterin synthesis, and i.-arginine metabolism in human and
murine macrophages.
NOTE. Cytosolic NOS activity was measured in duplicate experiments
with ceillysates from activated (100 units of interferon-v/rnl, and 200 ng of
endotoxin/rnl, for 48 h) and nonactivated cells and (5 X 107 human and
murine macrophages/assay). Lower values were from nonactivated cells.
higher values from activated cells. No activity was found in vesicular frac-
tion of murine and human cells or totallysates from human cells. Sensitivity
level ofassay was 0.3 J.LmoljI06 cells/h. Comparison ofcytosolic tetrahydro-
biopterin, essential cofactor of NOS. is from [38. 39].
times more L-arginine than any of the other L-amino acids
(not shown).
Finally, we turned to a direct measurement of NOS activ-
ity in cell lysates and subcellular fractions of human and
murine macrophages. In a system in which NADPH and
BH 4 , two essential cofactors of NOS, as well as the substrate
L-arginine are supplied in optimal concentrations [37], we
were unable to detect NOS activity in subcellular fractions of
human macrophages, while murine macrophages consis-
tently showed NOS activity that increased after induction by
LPS and IFN-y (table 2).
and TNFa [3] or IFN-y combined with TNFa [20]. In those
two studies, however, it was not excluded that the terminal
oxidases of the microorganisms, cocultured with macro-
phages, rather than the phagocytes had produced the nitrite
recovered from supernatants [3, 20].
To end this controversy, we extended previous studies on
NOS activity, NO production, and amino acid metabolism in
human mononuclear phagocytes. Our attempts to induce
macrophages to secrete NO in detectable amounts (~O.l
JLmoljl06 cells/24 h) by activation with LPS, IFN-y, TNFa,
GM-CSF, intact bacteria, or proliferating lymphocytes, all
potent stimuli for the induction of NOS in murine or rat
macrophages, completely failed, while parallel studies with
murine macrophages confirmed previous observations that
resident and elicited peritoneal macrophages secret NO in a
micromolar range, an activity that increases after activation
up to 40-60 umol/ 106 cells/24 h. Even a prolonged activa-
tion for up to 12 days was without effect on the capability of
human macrophages to produce NO. The disparity between
human and murine cells did not depend on the anatomic
source of the phagocyte, because human peritoneal cells and
blood-derived macrophages, in accordance with previous re-
ports [21, 23], behaved comparably. Furthermore, rabbit
mononuclear phagocytes derived from the blood or from the
peritoneal cavity concurrently did not produce NO. Accord-
ingly, it has previously been reported that thioglycolate-elic-
ited macrophages from rabbits do not metabolize L-arginine
to NO and citrulline [41].
A failure to detect NOS activity in human mononuclear
phagocytes could theoretically be explained by a deficiency
of BH4 , an essential cofactor of NOS [38, 39, 42]. Human
mononuclear phagocytes lack the enzyme systems required
for the complex biosynthesis ofBH4 and would, therefore, in
clear distinction to murine macrophages, depend on an exog-
enous BH4 source for NO synthesis, a hitherto neglected
idea. However, even when BH4 was substituted or when mac-
rophages were cultured in the presence of proliferating lym-
phocytes that could provide BH 4 [39], no NO was produced.
Another explanation for the failure to demonstrate NO
production by human macrophages could be that in contrast
to murine systems, for some reasons NO could not be mea-
sured as nitrite in culture supernatants. Also, this possibility
was excluded by the observation that human blood-derived
and peritoneal macrophages, in contrast to murine cells, do
not metabolize L-arginine to citrulline.
Finally, the absence ofdetectable NOS activity in total cell
Iysates. the cytosol, or the vesicular fraction of activated hu-
man macrophages speaks against an artificial deficit in sub-
strate or cofactors of NOS in vitro. This is because all cofac-
tors for maximal enzyme activity are provided in the assay
that worked in parallel wells with murine cell lysates (this
study) and in lysates ofhuman hepatocytes [43], human cells
that indeed have NOS activity.
In summary, these rigidly controlled studies, each accom-
<0.1
10-20
<0.1
<0.1
<0.1
<0.3
<0.03
Human
macrophages
10-90
1.4-2.2
2-60
600-800
Up to 60
500-700
800-1100
Murine
macrophages
NO has been proposed as an important antimicrobial and
antitumoral effector system of mononuclear phagocytes
from laboratory animals. More and more observations on
antimicrobial and cytotoxic effects of NO and the regulation
of its production by macrophages appear in the literature,
reflecting the enormous interest in this effector system (re-
viewed in [26-28, 40]). Our increasing knowledge of the
NOS of rodent macrophages contrasts with the scarcity of
data on a counterpart of this enzyme system in human mono-
nuclear phagocytes.
Previous studies have cast doubt on the existence of a
high-output NOS in human mononuclear phagocytes that
could be induced to produce NO in consequential amounts
[21, 23-25]. Only two studies have proposed that human
macrophages produce NO by demonstrating nitrite in a mi-
cromolar range in supernatants from human blood-derived
macrophages stimulated for extended periods with GM-CSF
Parameter
(per 106 cells/24 h)
Nitrite secretion (J.Lmol)
L-arginine consumption (J.Lmol)
Citrulline production (J.Lmol)
Ornithine production (J.Lmol)
U rea production (umol)
Cytosolic NOS activity
(J.Lmol/ I06 cells/h)
Cytosolic tetrahydrobiopterin
(pmoljmg)
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panied by positive control experiments, showed that human
macrophages, even when activated by numerous stimuli,
have no NOS compared with the high activity of the induc-
ible high-output NOS in murine macrophages. The failure to
document NOS activity in human macrophages has been re-
garded in the past by some authorities as an in vitro artifact
or has prompted speculations on unprecedented cofactors
operative in human but not murine NOS in macrophages.
These speculations must be strictly limited to macrophages
because the in vitro demonstration of inducible high-output
NOS activity is not associated with obstacles in human hepa-
tocytes or their lysates [43].
Therefore, it is time to change our assumptions and to
accept that human macrophages do not possess the high-out-
put NOS of murine macrophages as they do not possess sys-
tems for the synthesis of its important cofactor, BH4 . Inter-
species variations in the spectrum of nonoxidative killing
systems of phagocytes are not without precedent, as shown
with the defensin family of antibiotic peptides [44, 45]. We
propose that in humans and most probably also in the rabbit,
the inducible high-output NOS of macrophages that is opera-
tive in several other mammal species is not conserved as an
antimicrobial system, possibly because phagocytic killing
systems are redundant in mammals.
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